289 related articles for article (PubMed ID: 9131009)
1. A comparison of the effects of ifosfamide vs. mafosfamide treatment on intracellular glutathione levels and immunological functions of immunocompetent lymphocyte subsets.
Botzler C; Kis K; Issels R; Multhoff G
Exp Hematol; 1997 Apr; 25(4):338-44. PubMed ID: 9131009
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of ifosfamide on the capacity of cytotoxic T lymphocytes and natural killer cells to lyse their target cells correlate with intracellular glutathione levels.
Multhoff G; Meier T; Botzler C; Wiesnet M; Allenbacher A; Wilmanns W; Issels RD
Blood; 1995 Apr; 85(8):2124-31. PubMed ID: 7718883
[TBL] [Abstract][Full Text] [Related]
3. Glutathione modulates activation-dependent proliferation of human peripheral blood lymphocyte populations without regulating their activated function.
Smyth MJ
J Immunol; 1991 Mar; 146(6):1921-7. PubMed ID: 2005386
[TBL] [Abstract][Full Text] [Related]
4. Effect of interleukin-12 on antitumor activity of human umbilical cord blood and bone marrow cytotoxic cells.
Condiotti R; Nagler A
Exp Hematol; 1998 Jul; 26(7):571-9. PubMed ID: 9657131
[TBL] [Abstract][Full Text] [Related]
5. Bacterial activation of human natural killer cells. Characteristics of the activation process and identification of the effector cell.
Tarkkanen J; Saksela E; Lanier LL
J Immunol; 1986 Oct; 137(8):2428-33. PubMed ID: 3093576
[TBL] [Abstract][Full Text] [Related]
6. Regulation by glutathione of the effect of lymphokines on differentiation of primary activated lymphocytes. Influence of glutathione on cytotoxic activity of CD3-AK-.
Liang SM; Liang CM; Hargrove ME; Ting CC
J Immunol; 1991 Mar; 146(6):1909-13. PubMed ID: 1826013
[TBL] [Abstract][Full Text] [Related]
7. Purine metabolites suppress proliferation of human NK cells through a lineage-specific purine receptor.
Miller JS; Cervenka T; Lund J; Okazaki IJ; Moss J
J Immunol; 1999 Jun; 162(12):7376-82. PubMed ID: 10358189
[TBL] [Abstract][Full Text] [Related]
8. Effects of ifosfamide on immunocompetent effector cells.
Multhoff G; Botzler C; Allenbacher A; Issels R
Cancer Immunol Immunother; 1996 May; 42(4):251-4. PubMed ID: 8665573
[TBL] [Abstract][Full Text] [Related]
9. Leu-11+ lymphocytes with natural killer (NK) activity are precursors of recombinant interleukin 2 (rIL 2)-induced activated killer (AK) cells.
Itoh K; Tilden AB; Kumagai K; Balch CM
J Immunol; 1985 Feb; 134(2):802-7. PubMed ID: 3917475
[TBL] [Abstract][Full Text] [Related]
10. Requirement of thiol compounds as reducing agents for IL-2-mediated induction of LAK activity and proliferation of human NK cells.
Yamauchi A; Bloom ET
J Immunol; 1993 Nov; 151(10):5535-44. PubMed ID: 8228244
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of norepinephrine-mediated inhibition of human NK cytotoxic functions: inhibition of cytokine secretion, target binding, and programming for cytotoxicity.
Gan X; Zhang L; Solomon GF; Bonavida B
Brain Behav Immun; 2002 Jun; 16(3):227-46. PubMed ID: 12009684
[TBL] [Abstract][Full Text] [Related]
12. The role of glutathione in lymphocyte activation. I. Comparison of inhibitory effects of buthionine sulfoximine and 2-cyclohexene-1-one by nuclear size transformation.
Hamilos DL; Wedner HJ
J Immunol; 1985 Oct; 135(4):2740-7. PubMed ID: 4031498
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells.
Rasmusson I; Ringdén O; Sundberg B; Le Blanc K
Transplantation; 2003 Oct; 76(8):1208-13. PubMed ID: 14578755
[TBL] [Abstract][Full Text] [Related]
14. Ifosfamide-based drug combinations: preclinical evaluation of drug interactions and translation into the clinic.
Vanhoefer U; Schleucher N; Klaassen U; Seeber S; Harstrick A
Semin Oncol; 2000 Feb; 27(1 Suppl 1):8-13. PubMed ID: 10697038
[TBL] [Abstract][Full Text] [Related]
15. High-dose selection with mafosfamide results in sensitivity to DNA cross-linking agents: characterization of hypersensitive cell lines.
Fritz G; Hengstler JG; Kaina B
Cancer Res; 1997 Feb; 57(3):454-60. PubMed ID: 9012473
[TBL] [Abstract][Full Text] [Related]
16. Abnormalities of peripheral blood T lymphocytes and natural killer cells in alcoholic hepatitis persist after a 3-month withdrawal period.
Laso FJ; Madruga JI; López A; Ciudad J; Alvarez-Mon M; San Miguel J; Orfao A
Alcohol Clin Exp Res; 1997 Jun; 21(4):672-6. PubMed ID: 9194923
[TBL] [Abstract][Full Text] [Related]
17. Regulation by glutathione of the activation and differentiation of IL-4-dependent activated killer cells.
Hargrove ME; Wang J; Ting CC
Cell Immunol; 1993 Jul; 149(2):433-43. PubMed ID: 8330319
[TBL] [Abstract][Full Text] [Related]
18. Effect of cyclosporin A on interleukin-15-activated umbilical cord blood natural killer cell function.
Lin SJ; Kuo ML
Cytotherapy; 2008; 10(4):397-405. PubMed ID: 18574772
[TBL] [Abstract][Full Text] [Related]
19. Antileukemia activity of a natural killer cell line against human leukemias.
Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
[TBL] [Abstract][Full Text] [Related]
20. In vitro interleukin 12 activation of peripheral blood CD3(+)CD56(+) and CD3(+)CD56(-) gammadelta T cells from glioblastoma patients.
Fujimiya Y; Suzuki Y; Katakura R; Miyagi T; Yamaguchi T; Yoshimoto T; Ebina T
Clin Cancer Res; 1997 Apr; 3(4):633-43. PubMed ID: 9815731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
